2026 Scientific Sessions

Lunch Program: The Future of TAVR: Contemporary Practice and Evolutâ„¢ Platform Data

Evolut demonstrates a sustained commitment to clinical innovation by addressing the increasingly complex and evolving requirements of valve selection for patients undergoing TAVR. Explore clinical insights on the use of Evolut TAVR in low-risk patients and examine how pre-procedural planning can enhance procedural decision-making.
The Simplified Cusp Overlap Technique: The Why and How
Nicolo Piazza, M.D., Unaffiliated, Dollard-Des-Ormeaux, QC, CANADA
TAVR Durability: Contemporary Data in Low Risk and the Path Forward
Howard C. Herrmann, M.D., MSCAI, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
Valve Selection and Case Planning
Matthew W. Sherwood, M.D., FSCAI, Inova Fairfax Hospital, McLean, VA
Panel Discussion
Nicolo Piazza, M.D., Unaffiliated, Dollard-Des-Ormeaux, QC, CANADA, Anita W. Asgar, M.D., FSCAI, Northwestern University Feinberg School of Medicine, Chicago, IL, Matthew W. Sherwood, M.D., FSCAI, Inova Fairfax Hospital, McLean, VA and Howard C. Herrmann, M.D., MSCAI, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA